Boston Scientific (BSX) announced FDA 510(k) clearance for the Asurys Fluid Management System, designed to provide irrigation and distention during endoscopic urologic procedures, including ureteroscopies.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BSX:
- Boston Scientific Reports Strong HI-PEITHO Trial Results for EKOS
- Boston Scientific: CHAMPION AF Validates Watchman Safety, Supporting 20% LAAC Growth and Buy Rating
- Boston Scientific: Positive on Watchman LAAC as CHAMPION-AF Data Support First-Line Use, Label Expansion, and Upside to Growth
- Boston Scientific downgraded to Outperform from Strong Buy at Raymond James
- Buy Rating on Boston Scientific’s Watchman FLX Backed by Champion Trial Success and Accelerating LAAC Market Growth